{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:45:52Z","timestamp":1761965152839},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T00:00:00Z","timestamp":1288828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/2047-783x-15-s2-229","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T02:54:02Z","timestamp":1576032842000},"source":"Crossref","is-referenced-by-count":13,"title":["Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function"],"prefix":"10.1186","volume":"15","author":[{"given":"T. M.","family":"Zielonka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Demkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Radzikowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bialas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Filewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zycinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Obrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Wardyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Skopinska-Rozewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,4]]},"reference":[{"issue":"Suppl 32","key":"561_CR1","first-page":"2S","volume":"18","author":"M Demedts","year":"2001","unstructured":"Demedts M, Wells AU, Ant\u00f3 JM, Costabel U, Hubbard R, Cullinan P, Slabbynck H, Rizzato G, Poletti V, Verbeken EK, Thomeer MJ, Kokkarinen J, Dalphin JC, Taylor AN: Interstitial lung diseases: an epidemiological overview. Eur Respir J 2001,18(Suppl 32):2S-16S.","journal-title":"Eur Respir J"},{"issue":"2","key":"561_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1183\/09031936.97.10020280","volume":"10","author":"AU Wells","year":"1997","unstructured":"Wells AU, Rubens MB, du Bois RM, Hansell DM: Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography. Eur Respir J 1997,10(2):280\u20135. 10.1183\/09031936.97.10020280","journal-title":"Eur Respir J"},{"issue":"2","key":"561_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1152\/ajplung.00369.2007","volume":"294","author":"EJ Wagner","year":"2008","unstructured":"Wagner EJ, S\u00e1nchez J, McClintock JY, Jenkins J, Moldobaeva A: Inflammation and ischemia-induced lung angiogenesis. Am J Physiol Lung Cell Mol Physiol 2008,294(2):351\u20137.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5 Suppl 1","key":"561_CR4","doi-asserted-by":"publisher","first-page":"526S","DOI":"10.1378\/chest.128.5_suppl_1.526S","volume":"128","author":"RM Strieter","year":"2005","unstructured":"Strieter RM: Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005,128(5 Suppl 1):526S-32S.","journal-title":"Chest"},{"issue":"3","key":"561_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1164\/rccm.200202-135OC","volume":"167","author":"EA Renzoni","year":"2003","unstructured":"Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, Veeraraghavan S, Bishop AE, Romanska HM, Pantelidis P, Black CM, du Bois RM: Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 2003,167(3):438\u201343. 10.1164\/rccm.200202-135OC","journal-title":"Am J Respir Crit Care Med"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1465-9921-7-82","volume":"7","author":"A Tzouvelekis","year":"2006","unstructured":"Tzouvelekis A, Anevlavis S, Bouros D: Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? Respir Res 2006, 7: 82. 10.1186\/1465-9921-7-82","journal-title":"Respir Res"},{"issue":"4","key":"561_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/13813450312331337612","volume":"111","author":"C Navarro","year":"2003","unstructured":"Navarro C, Ruiz V, Gaxiola M, Carrillo G, Selman M: Angiogenesis in hypersensitivity pneumonitis. Arch Physiol Biochem 2003,111(4):365\u20138.","journal-title":"Arch Physiol Biochem"},{"issue":"11","key":"561_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1164\/rccm.200308-1111OC","volume":"169","author":"M Ebina","year":"2004","unstructured":"Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, Sasano H, Kondo T, Nukiwa T: Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004,169(11):1203\u20138. 10.1164\/rccm.200308-1111OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"561_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/0190-9622(95)91549-4","volume":"32","author":"M Carlesimo","year":"1995","unstructured":"Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S: Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995,32(5):866\u20139. 10.1016\/0190-9622(95)91549-4","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 4","key":"561_CR10","first-page":"259","volume":"14","author":"TM Zielonka","year":"2009","unstructured":"Zielonka TM, Demkow U, Zycinska K, Filewska M, Bialas B, Kus J, Radzikowska E, Remiszewski P, Szopinski J, Soszka A, Wardyn KA, Skopinska-Rozewska E: Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes. Eur J Clin Med 2009,14(Suppl 4):259\u201364.","journal-title":"Eur J Clin Med"},{"issue":"Suppl","key":"561_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1183\/09041950.005s1693","volume":"6","author":"PH Quanjer","year":"1993","unstructured":"Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report of working party, standardization of lung function tests. Eur Respir J 1993,6(Suppl):5\u201340.","journal-title":"Eur Respir J"},{"issue":"5","key":"561_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1084\/jem.141.5.1084","volume":"141","author":"YA Sidky","year":"1975","unstructured":"Sidky YA, Auerbach R: Lymphocyte-induced angiogenesis: a quantitative and sensitive assay for the graft-versushost reaction. J Exp Med 1975,141(5):1084\u2013100. 10.1084\/jem.141.5.1084","journal-title":"J Exp Med"},{"issue":"3","key":"561_CR13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4049\/jimmunol.159.3.1437","volume":"159","author":"MP Keane","year":"1997","unstructured":"Keane MP, Arenberg DA, Lynch JP, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Strieter RM: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997,159(3):1437\u201343.","journal-title":"J Immunol"},{"issue":"10","key":"561_CR14","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.4049\/jimmunol.162.9.5511","volume":"162","author":"MP Keane","year":"1999","unstructured":"Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, Burdick MD, Kunkel SL, Strieter RM: Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 1999,162(10):5511\u20138.","journal-title":"J Immunol"},{"issue":"5","key":"561_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00408-003-1028-8","volume":"181","author":"M Sekiya","year":"2003","unstructured":"Sekiya M, Ohwada A, Miura K, Takahashi S, Fukuchi Y: Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis. Lung 2003,181(5):259\u201365. 10.1007\/s00408-003-1028-8","journal-title":"Lung"},{"issue":"4","key":"561_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1272\/jnms.73.203","volume":"73","author":"A Tachihara","year":"2006","unstructured":"Tachihara A, Jin E, Matsuoka T, Ghazizadeh M, Yoshino S, Takemura T, Travis WD, Kawanami O: Critical roles of capillary endothelial cells for alveolar remodelling in nonspecific and usual interstitial pneumonias. J Nippon Med Sch 2006,73(4):203\u201313. 10.1272\/jnms.73.203","journal-title":"J Nippon Med Sch"},{"issue":"1","key":"561_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s004280050135","volume":"432","author":"E Tolnay","year":"1998","unstructured":"Tolnay E, Kuhnen C, Voss B, Wiethege T, M\u00fcller KM: Expression and localization of vascular endothelial growth factor and its receptor in pulmonary sarcoidosis. Virchows Arch 1998,432(1):61\u20135. 10.1007\/s004280050135","journal-title":"Virchows Arch"},{"issue":"Suppl 5","key":"561_CR18","first-page":"753","volume":"58","author":"TM Zielonka","year":"2007","unstructured":"Zielonka TM, Demkow U, Bialas B, Filewska M, Zycinska K, Radzikowska E, Szopinski J, Skopinska-Rozewska E: Modulatory effect of sera from sarcoidosis patients on mononuclear cells-induced angiogenesis. J Physiol Pharmacol 2007,58(Suppl 5):753\u201366.","journal-title":"J Physiol Pharmacol"},{"issue":"4","key":"561_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1378\/chest.130.4.982","volume":"130","author":"KM Antoniou","year":"2006","unstructured":"Antoniou KM, Tzouvelekis A, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Rachiotis G, Tzanakis N, Bouros D, Milic-Emili J, Siafakas NM: Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006,130(4):982\u20138. 10.1378\/chest.130.4.982","journal-title":"Chest"},{"issue":"3","key":"561_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10067-003-0698-1","volume":"22","author":"YT Konttinen","year":"2003","unstructured":"Konttinen YT, Mackiewicz Z, Ruuttila P, Ceponis A, Sukura A, Povilenaite D, Hukkanen M, Virtanen I: Vascular damage and lack of angiogenesis in systemic sclerosis skin. Clin Rheumatol 2003,22(3):196\u2013202. 10.1007\/s10067-003-0698-1","journal-title":"Clin Rheumatol"},{"issue":"4","key":"561_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","volume":"43","author":"M Hebbar","year":"2000","unstructured":"Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B: Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum 2000,43(4):889\u201393. 10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","journal-title":"Arthritis Rheum"},{"issue":"2","key":"561_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11926-007-0013-2","volume":"9","author":"MJ Mulligan-Kehoe","year":"2007","unstructured":"Mulligan-Kehoe MJ, Simons M: Current concepts in normal and defective angiogenesis: implications for systemic sclerosis. Curr Rheumatol Rep 2007,9(2):173\u20139. 10.1007\/s11926-007-0013-2","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"561_CR23","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1371\/journal.pmed.0040253","volume":"4","author":"B Senechal","year":"2007","unstructured":"Senechal B, Elain G, Jeziorski E, Grondin V, Patey-Mariaud de Serre N, Jaubert F, Beldjord K, Lellouch A, Glorion C, Zerah M, Mary P, Barkaoui M, Emile JF, Boccon-Gibod L, Josset P, Debr\u00e9 M, Fischer A, Donadieu J, Geissmann F: Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 2007,4(8):e253. 10.1371\/journal.pmed.0040253","journal-title":"PLoS Med"},{"issue":"4","key":"561_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.2003.009860","volume":"59","author":"NR Simler","year":"2004","unstructured":"Simler NR, Brenchley PE, Horrocks AW, Greaves SM, Hasleton PS, Egan JJ: Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax 2004,59(4):581\u20135.","journal-title":"Thorax"},{"issue":"8","key":"561_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/thx.2008.102814","volume":"64","author":"AG Richter","year":"2009","unstructured":"Richter AG, McKeown S, Rathinam S, Harper L, Rajesh P, McAuley DF, Heljasvaara R, Thickett DR: Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009,64(8):156\u201361.","journal-title":"Thorax"},{"issue":"3","key":"561_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.200409-1164OC","volume":"171","author":"MD Burdick","year":"2005","unstructured":"Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, Belperio JA, Strieter RM: CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodelling. Am J Respir Crit Care Med 2005,171(3):261\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"561_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4049\/jimmunol.179.1.708","volume":"179","author":"C Tabata","year":"2007","unstructured":"Tabata C, Tabata R, Kadokawa Y, Hisamori S, Takahashi M, Mishima M, Nakano T, Kubo H: Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J Immunol 2007,179(1):708\u201314.","journal-title":"J Immunol"},{"issue":"5","key":"561_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.pupt.2006.01.002","volume":"20","author":"KM Antoniou","year":"2007","unstructured":"Antoniou KM, Pataka A, Bouros D, Siafakas NM: Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 2007,20(5):453\u201361. 10.1016\/j.pupt.2006.01.002","journal-title":"Pulm Pharmacol Ther"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-15-S2-229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2047-783X-15-S2-229\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-15-S2-229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:15:35Z","timestamp":1695503735000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/2047-783X-15-S2-229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,4]]},"references-count":28,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/2047-783x-15-s2-229","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,4]]},"article-number":"229"}}